{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T17:03:07Z","timestamp":1779814987867,"version":"3.53.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.amjcard.2026.03.057","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:04:14Z","timestamp":1774371854000},"page":"159-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Estimated Stressed Blood Volume in Cardiac Amyloidosis: From Hemodynamic Insight to Clinically Actionable Risk Stratification"],"prefix":"10.1016","volume":"268","author":[{"given":"Rajesh Prasad","family":"Jayaswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.03.057_bib0001","doi-asserted-by":"crossref","unstructured":"Vanhentenrijk S, Augusto SN, Jr, Martens P, Ives L, Bhattacharya S, Carmona-Rubio A, Finet JE, Jacob M, Martyn T, Valent J, Hanna M, Burkhoff D, Tang WHW. Estimated stressed blood volume in patients with cardiac amyloidosis. Am J Cardiol 2026. https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.025.","DOI":"10.1016\/j.amjcard.2026.02.025"},{"key":"10.1016\/j.amjcard.2026.03.057_bib0002","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.jacc.2022.02.050","article-title":"Venous tone and stressed blood volume in heart failure: JACC review topic of the week","volume":"79","author":"Fudim","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.03.057_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010078","article-title":"Hemodynamic profiling and prognosis in cardiac amyloidosis","volume":"16","author":"Martens","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2026.03.057_bib0004","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/ehf2.14621","article-title":"Invasive haemodynamics at rest and exercise in cardiac amyloidosis","volume":"11","author":"Holt","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2026.03.057_bib0005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jaccao.2022.07.007","article-title":"Prognosis of transthyretin cardiac amyloidosis without heart failure symptoms","volume":"4","author":"Gonzalez-Lopez","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.amjcard.2026.03.057_bib0006","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.03.057_bib0007","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jaccao.2024.05.001","article-title":"Race and socioeconomic status impact diagnosis and clinical outcomes in transthyretin cardiac amyloidosis","volume":"6","author":"Shankar","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.amjcard.2026.03.057_bib0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/HCO.0000000000001156","article-title":"Treatment of transthyretin cardiac amyloidosis","volume":"39","author":"Bampatsias","year":"2024","journal-title":"Curr Opin Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926002006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926002006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:08:47Z","timestamp":1779811727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926002006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":8,"alternative-id":["S0002914926002006"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.03.057","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimated Stressed Blood Volume in Cardiac Amyloidosis: From Hemodynamic Insight to Clinically Actionable Risk Stratification","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.03.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}